{{Rsnum
|rsid=7805828
|Chromosome=7
|position=22718943
|Orientation=plus
|GMAF=0.3439
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 47.8 | 37.2
| HCB | 9.6 | 46.7 | 43.7
| JPT | 4.4 | 29.2 | 66.4
| YRI | 16.3 | 46.9 | 36.7
| ASW | 17.9 | 48.2 | 33.9
| CHB | 9.6 | 46.7 | 43.7
| CHD | 6.5 | 41.7 | 51.9
| GIH | 10.9 | 40.6 | 48.5
| LWK | 6.4 | 43.6 | 50.0
| MEX | 12.3 | 40.4 | 47.4
| MKK | 16.0 | 40.4 | 43.6
| TSI | 20.6 | 44.1 | 35.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=19965896
|Title=PTGS2 and IL6 Genetic Variation and Risk of Breast and Prostate Cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3)
|OA=1
}}

{{PMID Auto
|PMID=22258388
|Title=Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}